Published October 3, 2024
| Version 4
Journal
Open
CRITERION VALIDATION OF 'ADHD RELATED ITEMS' IN INCLEN: NDST AGAINST AIIMS MODIFIED INDT-ADHD AMONG CHILDREN WITH DEVELOPMENTAL PROBLEMS
Authors/Creators
Contributors
- 1. 1. Emeritus Professor, Noorul Islam Centre for Higher Education (NICHE), Deemed-to-be University, Kumarakovil, Kanyakumari District &Director, NIMS-Spectrum-CDRC, Aralumoodu, Thiruvananthapuram. 2. IAP Fellowship Trainee in Developmental & Behaviroual Pediatrics, NIMS-Spectrum-CDRC, Aralumoodu, Thiruvananthapuram. 3. IAP Fellowship in Developmental Nurse Counsellor Trainee, NIMS-Spectrum-CDRC, Aralumoodu, Thiruvananthapuram. 4.Formerly Associate Professor & Clinical Epidemiologist, Department of Community Medicine, GMC, Tvpm. 5. Developmental Nurse Counsellor, NIMS-Spectrum-CDRC, Aralumoodu, Thiruvananthapuram. 6. Senior Developmental Therapist, NIMS-Spectrum-CDRC, Aralumoodu, Thiruvananthapuram.
Description
Abstract: Attention deficit hyperactivity
disorder (ADHD) is one of the most common
neurodevelopmental disorders of childhood
with a global prevalence of 3-5% in school-aged
children.
Objectives: The primary objective of the study was
to assess the criterion validity of ADHD-related
items in the Neurodevelopmental screening tool
(NDST) against AIIMS-modified INDT-ADHD
as Gold standard using sensitivity, specificity,
predictive values, diagnostic accuracy, and
likelihood ratios.
Methods: This was a descriptive study - diagnostic
test evaluation carried out at NIMS Spectrum-
CDRC, Thiruvananthapuram, a tertiary care center
for children with neurodevelopmental problems.
50 consecutive children who came to CDRC for
suspected developmental problems were screened
initially with ADHD-relateditemsin NDST by
an experienced developmental therapist and
Files
RESERCH ARTICLE-2 (REVISED).pdf
Files
(294.7 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:7384d1bc6e294add4bb6c5c68e5e968b
|
294.7 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-09-28
References
- (12) Ocotber 2024 | Volume 2 | Issue 4 Aadarsh Pvt. Ltd. Indian Journal of Developmental & Behavioral Pediatrics (Official Journal of IAP Chapter of Neurodevelopmental Pediatrics) References: 1. Mowlem FD, Rosenqvist MA, Martin J, Lichtenstein P, Asherson P, Larsson H. Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment. Eur Child Adolesc Psychiatry. 2019 Apr;28(4):481-489. doi: 10.1007/s00787-018-1211-3. 2. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and meta-regression analysis. Am J Psychiatry. 2007 Jun;164(6):942- 8. doi: 10.1176/ajp.2007.164.6.942. 3. Srinath S, Girimaji SC, Gururaj G, Seshadri S, Subbakrishna DK, Bhola P, Kumar N. Epidemiological study of child & adolescent psychiatric disorders in urban & rural areas of Bangalore, India. Indian J Med Res. 2005 Jul;122(1):67-79. 4. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text rev. DSM-IV-TR. Washington, DC: AmericanPsychiatric Association; 2000. 5. Barkley RA. Psychosocial treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry. 2002;63 Suppl 12:36-43. PMID: 12562060. 6. Levy F, Hay DA, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):737-44. doi: 10.1097/00004583-199706000-00009. 7. Mukherjee S, Aneja S, Russell PS, Gulati S, Deshmukh V, Sagar R, Silberberg D, Bhutani VK, Pinto JM, Durkin M, Pandey RM, Nair MKC, Arora NK; INCLEN Study Group. INCLEN diagnostic tool for attention deficit hyperactivity disorder (INDT-ADHD): development and validation. Indian Pediatr. 2014 Jun;51(6):457-62. doi: 10.1007/s13312-014-0436-6. 8. Durkin MS, Schneider H, Pathania VS, Nelson KB, Solarsh GC, Bellows N, et al.Learning and developmental disabilities. In: Jamison DT, Breman JG, MeashamAR, editors Disease control priorities in low- and middle-income countries. 2nd, Ed NewYork: Oxford University Press and World Bank; 2006. Pp. 933–952 9. Bitta MA, Kipkemoi P, Kariuki SM, Abubakar A, Gona J, Philips-Owen J, Newton CR. Validity and reliability of the Neurodevelopmental Screening Tool (NDST) in screening for neurodevelopmental disorders in children living in rural Kenyan coast. Wellcome Open Res. 2021 Jun 2;6:137. doi: 10.12688/wellcomeopenres.16765.1. 10. UN World Health Organization (WHO). 58th World Health Assembly: Resolutions and Decisions, Annex. Geneva: World Health Organization, 2005 11. Gulati S, Saini L, Kaushik JS, Chakrabarty B, Arora NK, Pandey RM, Sagar R, Sapra S, Sharma S, Paul VK. The Development and Validation of DSM 5-Based AIIMS-Modified INDT ADHD Tool for Diagnosis of ADHD: A Diagnostic Test Evaluation Study. Neurol India. 2020 Mar- Apr;68(2):352-357. doi: 10.4103/0028-3886.280638. 12. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5). Washington,DC: American Psychiatric Association, 2013.Indian Journal of Developmental & Behavioral Pediatrics (Official Journal of IAP Chapter of Neurodevelopmental Pediatrics) 13. Ragnarsdottir B, Hannesdottir DK, Halldorsson F, Njardvik U. Gender and age differences in social skills among children with ADHD: peer problems and prosocial behavior. Child & Family Behavior Therapy. 2018 Oct 2;40(4):263-78. 14. Skogli EW, Teicher MH, Andersen PN, Hovik KT, Øie M. ADHD in girls and boys--gender differences in co-existing symptoms and executive function measures. BMC Psychiatry. 2013 Nov 9;13:298. doi: 10.1186/1471-244X-13-298. 15. Gershon J. A meta-analytic review of gender differences in ADHD. J AttenDisord. 2002 Jan;5(3):143-54. doi: 10.1177/108705470200500302.